ccRCC is also one of the most common manifestations of von Hippel Lindau (VHL) syndrome, where inactivation of the pVHL tumor suppressor, a component of the E3 ubiquitin ligase complex targeting HIF-1α for degradation, leads to development of lethal ccRCC in patients9. This evidence concerns the gene VHL and von Hippel-Lindau disease.